# Allergen Research

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/allergen-research

- Industry: Pharmaceuticals
- Headquarters: Menlo Park, US
- Website: www.allergenresearch.com
- Total disclosed funding: $17M
- Latest round: Series A (Nov 21, 2013)
- Investors on record: 1

## About

Allergen Research Corp. specializes in providing a premium domain name for sale, aimed at enhancing the visibility and credibility of businesses within allergen research and health sectors.Founded in 2011, Allergen Research Corp. operates from Menlo Park, US, focusing on offering its domain name to entities involved in allergen research. The company has raised a total of USD 80 mn in its Series B funding round on March 12, 2015, having completed 2 deals to date.AllergenResearch.com primarily offers a domain name for sale, serving as a digital asset for businesses and individuals in the allergen research sector. This domain enhances online visibility for companies engaged in allergen-related research, product development, and education, targeting a diverse clientele including researchers and healthcare providers globally.The revenue model for AllergenResearch.com is based on the sale of its domain name, priced at USD 8,195 or through a monthly payment plan of USD 682.92 for 12 months, facilitating transactions with both individual consumers and businesses.Allergen Research Corp. aims to leverage its recent Series B funding of USD 80 mn to expand its market presence. Plans include targeting new geographic regions for potential buyers looking to enhance their online presence in allergen research. Specific new products or services are not outlined at this time.

## Funding rounds

- Series A, Nov 21, 2013, $17M — Longitude Capital

## Investors

- Longitude Capital (https://capitalatlas.ai/funds/longitude-capital) — Series A